Neurona Therapeutics
Clinical trials sponsored by Neurona Therapeutics, explained in plain language.
-
Brain cell injection aims to quiet seizures in Drug-Resistant epilepsy
Disease control Recruiting nowThis early-stage trial tests a single injection of special nerve cells (NRTX-1001) into both sides of the brain for people with severe epilepsy that doesn't respond to medication. The goal is to see if it's safe and can reduce seizure frequency. Only 10 adults aged 18-75 with con…
Phase: PHASE1, PHASE2 • Sponsor: Neurona Therapeutics • Aim: Disease control
Last updated May 01, 2026 12:28 UTC
-
Brain cell transplant could tame severe epilepsy
Disease control Recruiting nowThis study tests a one-time injection of special nerve cells (NRTX-1001) into the brain for people with drug-resistant epilepsy. The cells release a calming chemical to reduce seizures. About 88 adults will be enrolled to see if it is safe and cuts down seizure frequency compared…
Phase: PHASE3 • Sponsor: Neurona Therapeutics • Aim: Disease control
Last updated May 01, 2026 12:27 UTC